PTGS2 and prostate carcinoma: EBPS inhibited and treated prostate cancer in male rats via various pathways, including suppressing oxidative stress and COX-2 overexpression, 5α reductase, Na+/K+ ATPase α-subunit, and testosterone biosynthesis, which were demonstrated as cancer promoters and anti-apoptotic stimulators.